The government in a statement said, it has decided to cap the price for "chikungunya serology IgM at Rs 600 and for RT PCR for chikungunya at Rs 1,500".
It also warned private hospitals and laboratories and nursing homes against overcharging.
With spurt in dengue cases, Delhi government last month capped at Rs 600 the cost of test to diagnose the vector-borne disease and Rs 50 for ascertaining the platelet count in private hospitals in the national capital.
Last year also, the AAP government had capped the dengue test charges following complaints that many private hospitals and laboratories were overcharging, sensing an opportunity to make profit.
Chikungunya cases in Delhi have shot up to 432 a massive rise in the figure released by civic authorities, who had reported just 20 cases till last week.
According to a municipal report released yesterday, 432 cases had been diagnosed in the national capital till August 27. Safdarjung Hospital had reported nearly 250 cases till August 29.
Till August 20, 311 cases of the vector-borne disease were reported while 176 cases came to light in last week alone, marking a rise of nearly 57 per cent.
An 18-year-old boy died Sunday of dengue at Apollo Hospital in south Delhi, taking to five the number of fatalities due to the vector-borne disease.
Delhi Health Minister Satyendar Jain said, "We have 10,000 beds and the number of fever clinics has been increased from 55 last year to 355. People should not panic.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
